Arcturus Therapeutics Holdings Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition

7.01,9.01

2.02,9.01

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

No description available

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Automatic Shelf Registration

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Required Information in Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

FARRELL PETER C

Marantz Jing L.

Marquet Magda

Slaoui Moncef

Markels John

BARLOW JAMES F

HOLMES EDWARD W

MULROY DENNIS

MULROY DENNIS

ARK Investment Management LLC

VANGUARD GROUP INC

BALYASNY ASSET MANAGEMENT L.P.

ARK Investment Management LLC

FEDERATED HERMES, INC.

Roberts Joseph

Roberts Joseph

Chivukula Pad

Payne Joseph E

Kurata Lance

BALYASNY ASSET MANAGEMENT L.P.

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

1.01,3.03,5.02,5.03,5.05,8.01,9.01

Correspondence with the SEC